Do Payers Pay More If Drug Risks Are Not Disclosed? GSK Seeks Supreme Court Answer

GlaxoSmithKline petitions court to review third party payers' RICO claims in Avandia litigation; PhRMA cites 'growing torrent' of such suits against drug makers.